Diabetes' Drugs Avandia and Actos
A panel of outside FDA advisers will be asked what types of studies should be conducted in order to evaluate the safety of diabetes' drugs Avandia and Actos, both of which have been linked to...
FDA & Prescription Drugs
Related Articles
Glaxo AIDS Drug Doubles Heart Attack Risk
In a study published in the Lancet medical journal, Glaxo SmithKline's AIDS drug Ziagen doubles the risk of heart attack. In the wake of the published study, AIDS doctors are urging caution before...
Congress Starts Asking Questions About Dr. Jarvik
Dr. Robert Jarvik became known as the maker of the world's first artificial heart in the 1980's. Most recently, his face and name are splashed in tv and print media ads pitching Pfizer's cholesterol drug Lipitor. The marketing campaign is so often used that Congress has started asking Pfizer questions about Dr. Jarvik's qualifications to pitch a cholesterol drug. The Wall St. Journal...
Older Patients Who Take Avandia Have Higher Risk of Heart Attacks
According to an article published in the Journal of the American Medical Association older people who suffer from diabetes and take Avandia as part of their treatment regimen are 60% increased risk of heart failure, a 40% increased risk of heart attack, and a 30% increased risk of death. This is obviously not good news for Glaxo Smith Kline, the manufacturer of Avandia. Avandia is a...
Genentech's Move to Restrict Use of Cheaper Avastin Leads to Probe
Genentech, the maker of Avastin, has sought to restrict access to its cheaper drug Avastin so that health officials will use a more expensive brand has lead to Congressional criticism. The restriction on the eye disease drug has led one US senator to write letters to the Centers for Medicare and Medicaid and the FDA inquiring as to the propriety of Genentech's actions. Senator Kohl of...
Dietary Supplement Recall
Bodee LLC has issued a voluntary recall of all its Encore dietary supplements after the FDA determined that a chemical analyis of the supplement contained harmful, undeclared ingredients. The FDA analysis showed that Encore Tabs contained aminotadalafil, an analog of tadalafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED). FDA maintains Aminotadalafil is close...
Senate Bill Would Allow FDA Monitoring of Over the Counter Drug Ads
A bill introduced by Senators Henry Waxman of California and Ted Kennedy of Massachusetts would give the FDA regulatory authority concerning ads for over the counter drugs. The bill comes in the wake of an FDA advisory about banning cold medicines for children under the age of 6. The new bill would give the federal agency power to impose monetary fines on advertisers. Presently, over the...
Novartis Chief Executive Says FDA Succumbing to Political Pressure in its Attempt to Increase Drug Safety
During the three day Clinton Global Initiative, Novartis Chief Executive Dan Vasella said that the FDA was buckling under political pressure to monitor the safety and efficacy of new pharmaceuticals. HIs comments were made in the wake of rising awareness of overly aggressive marketing tacticts by pharmaceutical companies at the expense of consumer safety. Two Novartis drugs, Prexige and Galvus...
FDA Cites Cold Medicine Dangers for Children
Cold and cough medicines purchased over the counter for children under six years of age can cause serious side effects, including death, concluded an FDA analysis of the safety of children's cold and cough medicines. The FDA has had 54 reports of children's death as a result of using decongesants containing pseudoephedrine, phenylephrine and ephedrine. The FDA has told companies marketing...
FDA Warning Issued for Pain Drug Fentora
Fentora, used to treat pain in cancer patients, has drawn an FDA warning as a result of deaths in patients who were given the improper dosage or Fentora was incorrectly substituted as a pain management pharmaceutical. The FDA warning stated that Fentora should not be used in cancer patients who are unable to tolerate other opioiddrugs. Fentora was approved by the FDA last year for cancer...
